Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001544 · ClinicalTrials.gov registry record
Genetic Aspects of Neurologic and Psychiatric Disorders
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 1,227
- Enrollment target
NCT00001544 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 1,227 participants.
The verdict
NCT00001544 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 1,227 participants
- Enrollment target
Study Summary
The purpose of this study is to improve the understanding of the genetic causes of specific neurologic and psychiatric disorders. The study will focus on conditions of mental retardation, childhood onset schizophrenia, attention deficit hyperactivity disorder (ADHD), atypical psychosis of childhood, and bipolar affective disorder. The study addresses the belief that there may be several genes contributing to the illness. Researchers intend to use several molecular genetic techniques in order to identify the areas of chromosomes containing genes responsible for the development of these disorders. Patients will be selected to participate in this study based on an early age of onset of their condition as well as the severity of the illness and the frequency of the illness among family members. Researchers will collect DNA samples from patients as well as affected and unaffected family members of each patient. The DNA samples collected will be analyzed for a variety of genetic abnormalities including; triplet repeat expansions, chromosome rearrangements, and polymorphisms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,227 participants |
| Start Date | 1996-04 |
| Est. Completion | 2004-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001544
The ClinicalTrials.gov registry entry for NCT00001544 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001544 about?
NCT00001544 is a clinical study titled "Genetic Aspects of Neurologic and Psychiatric Disorders". The purpose of this study is to improve the understanding of the genetic causes of specific neurologic and psychiatric disorders. The study will focus on conditions of mental retardation, childhood onset schizophrenia, attention deficit hyperactivity disorder (ADHD), atypical psychosis of childhood,...
What is the current status of trial NCT00001544?
This trial is currently completed. The enrollment target is 1,227 participants. The study started on 1996-04. Estimated completion is 2004-03.
Who is sponsoring clinical trial NCT00001544?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.